vs
Aquestive Therapeutics, Inc.（AQST）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
Aquestive Therapeutics, Inc.的季度营收约是Digimarc CORP的1.5倍（$13.0M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -244.8%，领先197.6%），Aquestive Therapeutics, Inc.同比增速更快（9.7% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-8.6M），过去两年Aquestive Therapeutics, Inc.的营收复合增速更高（3.9% vs -5.3%）
Aquestive Therapeutics是一家特种制药企业，专注于中枢神经系统疾病创新疗法的开发与商业化。公司依托专有的药物递送技术打造便于患者使用的治疗方案，服务北美、欧洲市场的医疗机构与患者，核心管线覆盖神经学与精神病学领域的未满足医疗需求。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
AQST vs DMRC — 直观对比
营收规模更大
AQST
是对方的1.5倍
$8.9M
营收增速更快
AQST
高出6.8%
2.9%
净利率更高
DMRC
高出197.6%
-244.8%
自由现金流更多
DMRC
多$9.4M
$-8.6M
两年增速更快
AQST
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $8.9M |
| 净利润 | $-31.9M | $-4.2M |
| 毛利率 | 55.2% | 63.5% |
| 营业利润率 | -221.6% | -48.2% |
| 净利率 | -244.8% | -47.2% |
| 营收同比 | 9.7% | 2.9% |
| 净利润同比 | -86.8% | 51.4% |
| 每股收益（稀释后） | $-0.26 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AQSTDMRC
| Q4 25 | $13.0M | $8.9M | ||
| Q3 25 | $12.8M | $7.6M | ||
| Q2 25 | $10.0M | $8.0M | ||
| Q1 25 | $8.7M | $9.4M | ||
| Q4 24 | $11.9M | $8.7M | ||
| Q3 24 | $13.5M | $9.4M | ||
| Q2 24 | $20.1M | $10.4M | ||
| Q1 24 | $12.1M | $9.9M |
净利润AQSTDMRC
| Q4 25 | $-31.9M | $-4.2M | ||
| Q3 25 | $-15.4M | $-8.2M | ||
| Q2 25 | $-13.5M | $-8.2M | ||
| Q1 25 | $-22.9M | $-11.7M | ||
| Q4 24 | $-17.1M | $-8.6M | ||
| Q3 24 | $-11.5M | $-10.8M | ||
| Q2 24 | $-2.7M | $-9.3M | ||
| Q1 24 | $-12.8M | $-10.3M |
毛利率AQSTDMRC
| Q4 25 | 55.2% | 63.5% | ||
| Q3 25 | 64.8% | 58.3% | ||
| Q2 25 | 54.4% | 58.8% | ||
| Q1 25 | 58.1% | 65.0% | ||
| Q4 24 | 61.9% | 60.8% | ||
| Q3 24 | 67.2% | 62.4% | ||
| Q2 24 | 77.5% | 66.1% | ||
| Q1 24 | 63.6% | 62.5% |
营业利润率AQSTDMRC
| Q4 25 | -221.6% | -48.2% | ||
| Q3 25 | -89.6% | -109.7% | ||
| Q2 25 | -113.6% | -105.2% | ||
| Q1 25 | -222.1% | -128.9% | ||
| Q4 24 | -114.4% | -105.1% | ||
| Q3 24 | -61.2% | -120.4% | ||
| Q2 24 | 0.3% | -96.2% | ||
| Q1 24 | -74.3% | -109.2% |
净利率AQSTDMRC
| Q4 25 | -244.8% | -47.2% | ||
| Q3 25 | -120.6% | -106.9% | ||
| Q2 25 | -135.4% | -102.6% | ||
| Q1 25 | -263.0% | -125.2% | ||
| Q4 24 | -143.7% | -99.9% | ||
| Q3 24 | -85.0% | -113.9% | ||
| Q2 24 | -13.7% | -89.3% | ||
| Q1 24 | -106.4% | -104.0% |
每股收益（稀释后）AQSTDMRC
| Q4 25 | $-0.26 | $-0.18 | ||
| Q3 25 | $-0.14 | $-0.38 | ||
| Q2 25 | $-0.14 | $-0.38 | ||
| Q1 25 | $-0.24 | $-0.55 | ||
| Q4 24 | $-0.18 | $-0.40 | ||
| Q3 24 | $-0.13 | $-0.50 | ||
| Q2 24 | $-0.03 | $-0.43 | ||
| Q1 24 | $-0.17 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $12.9M |
| 总债务越低越好 | $27.5M | — |
| 股东权益账面价值 | $-33.7M | $40.2M |
| 总资产 | $160.4M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AQSTDMRC
| Q4 25 | — | $12.9M | ||
| Q3 25 | $129.1M | $12.6M | ||
| Q2 25 | $60.5M | $16.1M | ||
| Q1 25 | $68.7M | $21.6M | ||
| Q4 24 | $71.5M | $28.7M | ||
| Q3 24 | $77.9M | $33.7M | ||
| Q2 24 | $89.9M | $41.5M | ||
| Q1 24 | $95.2M | $48.9M |
总债务AQSTDMRC
| Q4 25 | $27.5M | — | ||
| Q3 25 | $45.0M | — | ||
| Q2 25 | $45.0M | — | ||
| Q1 25 | $45.0M | — | ||
| Q4 24 | $32.5M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $45.0M | — |
股东权益AQSTDMRC
| Q4 25 | $-33.7M | $40.2M | ||
| Q3 25 | $-4.1M | $41.4M | ||
| Q2 25 | $-72.6M | $46.5M | ||
| Q1 25 | $-60.9M | $50.0M | ||
| Q4 24 | $-60.2M | $61.4M | ||
| Q3 24 | $-45.4M | $70.2M | ||
| Q2 24 | $-35.5M | $77.2M | ||
| Q1 24 | $-36.3M | $84.5M |
总资产AQSTDMRC
| Q4 25 | $160.4M | $53.0M | ||
| Q3 25 | $163.6M | $55.4M | ||
| Q2 25 | $93.7M | $60.7M | ||
| Q1 25 | $102.2M | $66.5M | ||
| Q4 24 | $101.4M | $75.8M | ||
| Q3 24 | $110.0M | $85.0M | ||
| Q2 24 | $117.6M | $93.4M | ||
| Q1 24 | $129.5M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $-8.6M | $895.0K |
| 自由现金流率自由现金流/营收 | -65.7% | 10.0% |
| 资本支出强度资本支出/营收 | 0.7% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-53.0M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流AQSTDMRC
| Q4 25 | $-8.5M | $991.0K | ||
| Q3 25 | $-12.6M | $-2.6M | ||
| Q2 25 | $-7.9M | $-4.7M | ||
| Q1 25 | $-23.4M | $-5.5M | ||
| Q4 24 | $-6.5M | $-4.2M | ||
| Q3 24 | $-11.9M | $-7.1M | ||
| Q2 24 | $-7.0M | $-6.8M | ||
| Q1 24 | $-10.4M | $-8.4M |
自由现金流AQSTDMRC
| Q4 25 | $-8.6M | $895.0K | ||
| Q3 25 | $-12.9M | $-2.8M | ||
| Q2 25 | $-8.0M | $-4.9M | ||
| Q1 25 | $-23.5M | $-5.5M | ||
| Q4 24 | $-6.5M | $-4.2M | ||
| Q3 24 | $-12.0M | $-7.2M | ||
| Q2 24 | $-7.0M | $-6.9M | ||
| Q1 24 | $-10.4M | $-8.5M |
自由现金流率AQSTDMRC
| Q4 25 | -65.7% | 10.0% | ||
| Q3 25 | -100.6% | -36.9% | ||
| Q2 25 | -80.2% | -61.0% | ||
| Q1 25 | -269.9% | -59.1% | ||
| Q4 24 | -54.8% | -49.1% | ||
| Q3 24 | -88.3% | -75.7% | ||
| Q2 24 | -35.0% | -66.1% | ||
| Q1 24 | -86.4% | -85.8% |
资本支出强度AQSTDMRC
| Q4 25 | 0.7% | 1.1% | ||
| Q3 25 | 1.8% | 2.9% | ||
| Q2 25 | 1.1% | 2.5% | ||
| Q1 25 | 1.5% | 0.6% | ||
| Q4 24 | 0.1% | 0.2% | ||
| Q3 24 | 0.6% | 0.7% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 0.2% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AQST
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
